The Centers for Disease Control and Prevention contemplates the award of a contract to acquire up to ten million doses of Botulinum Toxoid(Vaccine), Trivalent Product (Serotype A,B,E). The Government is seeking competition from those firm/firms to have demonstrated they possess the necessary capability and capacity required for cGMP manufacture and licensure. The anticipated period of performance will be five years.Solicitation 200-2003-00981 will be issued on/or about September 30, 2003.
Bid Protests Not Available
G